Skip to Content

Omnicell Inc OMCL Stock Quote

| Rating as of


Last close prices updated as of Jun 09, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 72.24
  • Sector Healthcare
  • Industry Health Information Services
  • Investment Style Small Blend
  • Day Range 72.16  –  74.09
  • Year Range 46.11  –  125.17
  • Market Cap 3.2566 Bil
  • Volume / Avg 211,803.0 /  413,305.3
  • Price / Sales 2.57
  • Price / Book 2.85
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis OMCL

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics OMCL

Company Profile OMCL

Business Description

Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

2625 Augustine Drive, Suite 301
Santa Clara, CA, 95054
Industry Health Information Services
Employees 3,830

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of OMCL’s competitive advantage.

Omnicell Inc


Cardinal Health Inc


McKesson Corp

−$1.28 (1.74%) +$1.44 (1.69%) +$4.69 (1.21%)
Market Cap
3.26 Bil22.09 Bil53.42 Bil
Health Information Services Medical Distribution Medical Distribution

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Omnicell Inc Stock

No. OMCL does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

OMCL’s market cap is 3.26 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

OMCL’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

OMCL’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare OMCL’s historical performance against its industry peers and the overall market.